Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03822468 | Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer(AMALEE) | completed | Phase 2 | 376 | Novartis PharmaceuticalsINDUSTRY | 23 | Oct 16, 2025 | clinicaltrials |
| NCT05082610 | A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors | completed | Phase 1 | 48 | Hummingbird BioscienceINDUSTRY | 1 | Oct 16, 2025 |
| clinicaltrials |
| NCT02819362 | Benefit of a Diagnostic MRI in Case of Pathological Nipple Discharge With Normal Mammography / Ultrasound(IRM-sein) | completed | — | 70 | Institut BergoniéOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT02510456 | Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging(DOSI) | completed | — | 24 | Boston Medical CenterOTHER | 1 | Oct 14, 2025 | clinicaltrials |
| NCT05945927 | A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Therapy in Chinese Participants With HER2 Positive Advanced Breast Cancer | completed | — | 178 | Hoffmann-La RocheINDUSTRY | 1 | Oct 10, 2025 | clinicaltrials |
| NCT04023110 | Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab(CCTGuide Pilot) | completed | Phase 1 | 68 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Oct 9, 2025 | clinicaltrials |
| NCT06180460 | CALM: Managing Distress in Malignant Brain Cancer | completed | N/A | 60 | Virginia Commonwealth UniversityOTHER | 1 | Oct 8, 2025 | clinicaltrials |
| NCT06572800 | Tka Assay for CDK4/6i | completed | N/A | 34 | Yale UniversityOTHER | 1 | Oct 8, 2025 | clinicaltrials |
| NCT07211451 | Axillary Nodal Burden in HER2+ and TNBC | completed | — | 1,571 | Gangnam Severance HospitalOTHER | 1 | Oct 8, 2025 | clinicaltrials |
| NCT04863443 | Nonlinear Elasticity Mapping of Breast Masses | completed | — | 172 | Mayo ClinicOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT00462696 | MRI in Evaluating Early Response to Chemotherapy in Women With Infiltrating Breast Cancer(ISNA-Sein) | completed | N/A | 16 | Institut BergoniéOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT05599334 | A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib(NEAR) | completed | — | 111 | Pierre Fabre MedicamentINDUSTRY | 5 | Oct 6, 2025 | clinicaltrials |
| NCT07199556 | Impact of a Food Supplement on Musculoskeletal Pain in Women With Breast Cancer Treated With Aromatase Inhibitors.(DOLFLEX) | completed | N/A | 30 | Arafarma Group, S.A.INDUSTRY | 1 | Oct 3, 2025 | clinicaltrials |
| NCT02216162 | PROACTIVE Study Evaluation of the Impact of a Multidimensional Geriatric Intervention Program(PROACTIVE) | completed | N/A | 12 | Hospices Civils de LyonOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT04343807 | Effectiveness of Ultrasound Guided PECS Block on Opioid Consumption and Patient Satisfaction Through Adequate Pain Control Following Breast Cancer Surgery. | completed | N/A | 70 | Aga Khan UniversityOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT05921331 | RJBC-APP and Breast Cancer Treatment Compliance | completed | N/A | 540 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT06199050 | The Effect of 360° Virtual Reality Movies on Fear and Anxiety(ENGAGE) | completed | N/A | 292 | Maastricht Radiation OncologyOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT00210223 | Radiofrequency of Breast Cancers in Non Surgical Patients(RF-SEIN) | completed | N/A | 21 | Institut BergoniéOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT01754597 | Natriuretic Peptide Concentrations of B-type (BNP) During Anesthesia in Patients Previously Sensitized to Anthracyclines(PEP-NAT-B) | completed | N/A | 54 | Institut BergoniéOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT06580743 | Efficacy Verification in Early Diagnosis and Management of Lymphedema Through Home Body Water Analyzer | completed | — | 52 | University of MinnesotaOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT01982448 | Cisplatin vs Paclitaxel for Triple Negative Breast Cancer | completed | Phase 2 | 147 | Dana-Farber Cancer InstituteOTHER | 1 | Sep 30, 2025 | clinicaltrials |
| NCT03264547 | A Study to Compare Eribulin Mesylate + Pertuzumab + Trastuzumab With Paclitaxel or Docetaxel + Pertuzumab + Trastuzumab | completed | Phase 3 | 446 | Japan Breast Cancer Research GroupOTHER | 1 | Sep 29, 2025 | clinicaltrials |
| NCT04365569 | Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program | completed | N/A | 78 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 29, 2025 | clinicaltrials |
| NCT05501769 | ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer(TACTIVE-E) | completed | Phase 1 | 32 | Arvinas Estrogen Receptor, Inc.INDUSTRY | 2 | Sep 26, 2025 | clinicaltrials |
| NCT01742975 | Efficacy Study of Ifabond in Breast Cancer Surgery(Ifabond) | completed | N/A | 104 | Hôpital Européen MarseilleOTHER | 1 | Sep 25, 2025 | clinicaltrials |
| NCT03367572 | Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer | completed | Phase 3 | 1,363 | University of Rochester NCORP Research BaseOTHER | 1 | Sep 25, 2025 | clinicaltrials |
| NCT04259762 | Enhancing Cancer Prevention and Control Pathways-Native Health Initiative | completed | N/A | 508 | New Mexico Cancer Research AllianceOTHER | 1 | Sep 24, 2025 | clinicaltrials |
| NCT04343950 | SMS Messaging as a Tool to Improve Cancer Screening Programs(M-TICS) | completed | N/A | 44,601 | Institut Català d'OncologiaOTHER | 1 | Sep 24, 2025 | clinicaltrials |
| NCT06019325 | Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy | completed | N/A | 254 | Muğla Sıtkı Koçman UniversityOTHER | 1 | Sep 24, 2025 | clinicaltrials |
| NCT04664829 | The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC | completed | Phase 1 | 12 | National Cancer Centre, SingaporeOTHER | 1 | Sep 23, 2025 | clinicaltrials |
| NCT02186470 | Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer | completed | N/A | 22 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT04541537 | Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer. (KDOGCOV)(KDOG COV) | completed | N/A | 35 | Institut CurieOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT00210210 | Administration of Ketamine to Prevent the Post-operative Pain(KETAMINE) | completed | Phase 3 | 230 | Institut BergoniéOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT02839473 | Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial(HYDROSORB) | completed | Phase 3 | 278 | Institut CurieOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT04118062 | Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR) | completed | N/A | 128 | Institut CurieOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT04327063 | MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgery(MIRs 04) | completed | Phase 3 | 182 | Institut CurieOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT06188494 | UNFOLD Study Egypt | completed | — | 405 | AstraZenecaINDUSTRY | 1 | Sep 18, 2025 | clinicaltrials |
| NCT04292847 | LCCC1931:Post-treatment Intervention in Women With Breast Cancer (70y/o+) | completed | — | 5 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT05036083 | Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion | completed | N/A | 89 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT03778931 | Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer(EMERALD) | completed | Phase 3 | 478 | Stemline Therapeutics, Inc.INDUSTRY | 17 | Sep 15, 2025 | clinicaltrials |
| NCT03944499 | Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer. | completed | Phase 1 | 161 | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.INDUSTRY | 1 | Sep 15, 2025 | clinicaltrials |
| NCT05114005 | Tango for Neuropathy Among Breast Cancer Survivors | completed | N/A | 52 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT06504719 | Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan | completed | — | 312 | Hellenic Cooperative Oncology GroupOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT01841749 | Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast(CINNAMOME) | completed | — | 228 | Institut BergoniéOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT03096041 | Phase 3 Study Randomized Evaluating the Efficacy of Auriculotherapy in Patients With Musculoskeletal Pain by Aromatase Inhibitors(TRIPLE-A) | completed | N/A | 197 | Centre Francois BaclesseOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT06012786 | Myofascial Pain Syndrome in Patients With Breast Cancer-related Lymphedema | completed | — | 110 | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT06184074 | Effect of Aromatase Inhibitors on Ultrasonographic Measurements and Static and Dynamic Balance Scores in Breast Cancer | completed | — | 76 | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT06604078 | Breast Cancer AI Imaging Study | completed | — | 199 | University of Central FloridaOTHER | 1 | Sep 12, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Oct 16, 2025source: clinicaltrials